The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer

被引:4
|
作者
Prayudi, Pande Kadek Aditya [1 ,2 ]
Winata, I. Gde Sastra [1 ,2 ]
Mahendra, Nyoman Bayu [1 ,2 ]
Budiana, I. Nyoman Gede [1 ,2 ]
Saspriyana, Kade Yudi [1 ,2 ]
Suwiyoga, Ketut [1 ,2 ]
机构
[1] Prof Dr I GNG Ngoerah Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Denpasar 80113, Bali, Indonesia
[2] Udayana Univ, Fac Med, Denpasar 80113, Bali, Indonesia
来源
关键词
ovarian cancer; epithelial-to-mesenchymal transition; cellular reprogramming; PROMOTES VASCULOGENIC MIMICRY; HEDGEHOG SIGNALING PATHWAY; E-CADHERIN; CELL-MIGRATION; STEM-CELLS; TRANSCRIPTION FACTORS; CISPLATIN-RESISTANCE; POOR SURVIVAL; LNCRNA-ATB; EMT;
D O I
10.31083/j.ceog5012272
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To understand the basic mechanism and dynamic regulation that underlies the epithelial-to-mesenchymal transition (EMT) in ovarian cancer (OC) cells. Mechanism: A literature review using evidences from several data bases (i.e., PubMed, EMBASE, Web of Science, Medline, Cochrane, Science Direct, and Google Scholar) were conducted to describe the basic mechanism and dynamic regulation of EMT in OC cells. Finding in Brief: EMT is a complex epigenetic reprogramming orchestrated by specific transcription factors (TFs) and multiple upstream activators and regulators, such as transforming growth factor-0 (TGF-0), Wnt, Hedgehog, and Hippo signaling pathways. The net result of this cellular reprogramming is the acquisition of mesenchymal phenotypes with increased invasive and metastatic potential, stemness properties and chemoresistance. Recent studies have demonstrated that EMT activation is the result of dynamic and reciprocal interplay between OC cells and their tumor microenvironment (TME). Cellular or non-cellular component of TME, external factors related to TME such as hypoxia, oxidative stress, mechanical forces, as well as exposure to chemotherapy, all play significant role to EMT induction. Current understanding behind the mechanism of EMT induction in cancer cells have proposed the idea that EMT is not merely a binary process involving a complete conversion from epithelial to mesenchymal state, but rather a dynamic process that encompasses a range of hybrid states, a phenotype that has been referred to as "partial EMT". Cells with partial EMT have been known to be more apoptosis-resistant and have more tumor-initiating potential as compared to those with complete EMT. Conclusions: Understanding the complex regulatory network that underlies EMT in OC cells is crucial in order to gain insight in developing novel and effective treatment strategies for OC.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer
    N. P. A. Devika Gunasinghe
    Alan Wells
    Erik W. Thompson
    Honor J. Hugo
    Cancer and Metastasis Reviews, 2012, 31 : 469 - 478
  • [42] Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype
    Cervantes-Arias, A.
    Pang, L. Y.
    Argyle, D. J.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2013, 11 (03) : 169 - 184
  • [43] microRNA-181a plays a critical role in ovarian cancer progression through the regulation of epithelial-mesenchymal transition
    Parikh, Aditya
    Lee, Christine
    Joseph, Peronne
    Marchini, Sergio
    Baccarini, Alessia
    Kolev, Valentin
    Romualdi, Chiara
    Fruscio, Robert
    Shah, Hardik
    Feng, Wang
    Mullokandov, Gavriel
    Fishman, David
    D'Incalci, Maurizio
    Rahaman, Jamal
    Kalir, Tamara
    Redline, Raymond
    Brown, Brian D.
    Narla, Goutham
    DiFeo, Analisa
    CLINICAL CANCER RESEARCH, 2013, 19
  • [44] microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
    Parikh, Aditya
    Lee, Christine
    Joseph, Peronne
    Marchini, Sergio
    Baccarini, Alessia
    Kolev, Valentin
    Romualdi, Chiara
    Fruscio, Robert
    Shah, Hardik
    Wang, Feng
    Mullokandov, Gavriel
    Fishman, David
    D'Incalci, Maurizio
    Rahaman, Jamal
    Kalir, Tamara
    Redline, Raymond W.
    Brown, Brian D.
    Narla, Goutham
    Difeo, Analisa
    NATURE COMMUNICATIONS, 2014, 5
  • [45] Mechanism of Low Expression of miR-30a-5p on Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer
    Wang, Lei
    Zhao, Shanshan
    Yu, Mingxin
    DNA AND CELL BIOLOGY, 2019, 38 (04) : 341 - 351
  • [46] Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy
    Liu, Qiu-Luo
    Luo, Maochao
    Huang, Canhua
    Chen, Hai-Ning
    Zhou, Zong-Guang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] THE REGULATION OF DESMOSOMES IN EPITHELIAL-MESENCHYMAL TRANSITION
    Chen, Min-Che
    IUBMB LIFE, 2009, 61 (03) : 358 - 358
  • [48] REGULATION OF EPITHELIAL-MESENCHYMAL TRANSITION BY MICRORNAS
    Wager, Lucas J.
    Murray, Rachael Z.
    Leavesley, David I.
    Thompson, Erik W.
    WOUND REPAIR AND REGENERATION, 2016, 24 (06) : A21 - A21
  • [49] Unraveling epigenetic regulation of epithelial mesenchymal transition
    Kanlaya, Rattiyaporn
    Thongboonkerd, Visith
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1177 - S1180
  • [50] Epigenetic regulation of epithelial-mesenchymal transition
    Sun, Lidong
    Fang, Jia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2016, 73 (23) : 4493 - 4515